Lupin’s shares hit a fresh yearly high on January 19 after the pharma company received approval from the United States Food and Drug Administration (US...
Pharmaceutical major Lupin Ltd, on 22 December, announced that it has acquired a portfolio of established products in Europe and Canada for a total consideration...
Lupin, on 23 November, announced that it had received approval from the USFDA (United States Food and Drug Administration) for Canagliflozin Tablets, 100 mg and...